Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy

Journal of Pharmaceutical Investigation · Published 2025-03-25 · DOI 10.1007/s40005-025-00731-z

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40005-025-00731-z

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Bio-magnetic nanomedicine for targeted drug delivery of breast cancer: green synthesis, functional design, and translational challenges · Breast Cancer Research · 2026 · Cites or is cited by this article
• Advances in nano-delivery of natural products for cancer therapy: mechanisms and translational strategies · Biomedical Materials (Bristol) · 2026 · Cites or is cited by this article
• AS1411-functionalized albumin nanoparticles for nucleolin-targeted realgar delivery and therapy in triple-negative breast cancer · Frontiers in Pharmacology · 2026 · Cites or is cited by this article
• Dose optimization of omadacycline for the treatment of nontuberculous mycobacterial pulmonary disease (NTM-PD) using a physiologically based pharmacokinetic modeling approach · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Architecture-driven optimization of nanocarriers for pH-responsive drug delivery · Journal of Pharmaceutical Investigation · 2026 · Same journal
• From meal to medicine: exploring the roots and consequences of drug-food effects · Journal of Pharmaceutical Investigation · 2026 · Same journal
• Antimicrobial and thermostabilizing properties of a novel surfactant on different bacterial species · Journal of Pharmaceutical Investigation · 2026 · Same journal
• Mechanistic insights into the self-assembly and cellular uptake of thermoresponsive pNIPAM-grafted hyaluronic acid nanogels · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Exploring anti-integrin α6 antibody and transferrin-decorated dual drug-loaded liposomes as a promising nanoplatform for glioblastoma therapy: a preclinical approach · Journal of Pharmaceutical Investigation · 2025 · Same journal
• Necessity of considering sex factors in the clinical application of transdermal formulations · Journal of Pharmaceutical Investigation · 2025 · Same journal